The pelvis is curved. For three decades, the hardware to fix it wasn't. CurvaFix built a steerable implant that follows the bone.
In an operating room, the pelvis is one of the hardest places to work. It is a cage of curves and narrow bone corridors, and for a generation the standard repair meant bolting straight plates and screws onto its surface. CurvaFix, Inc., a medical device company in Bellevue, Washington, took a different position: if the bone is curved, the implant should be too.
The result is the CurvaFix IM Implant, described by the company as the first new intramedullary pelvic trauma technology in roughly 30 years, and the only device capable of following the natural shape of the pelvis while filling the space inside the bone. Instead of hardware pressed against the outside of the pelvis, a curved, steerable rodscrew is driven through the bone's own canal, delivering strong internal fixation through a single small incision.
Founded by surgeon Dr. Robert Meek, an internationally recognized pioneer in pelvic and acetabular fracture surgery, the company frames its work in plain terms - restoring mobility, improving lives - and aims it at one of medicine's quieter and fast-growing problems.
There is no dramatic cast, no visible break. A pelvic fragility fracture often looks like an older patient who suddenly cannot stand. These injuries are painful, immobilizing, and increasingly common: the company cites roughly 200,000 pelvic fractures a year in the U.S., a figure rising about 9% annually as the population ages.
Traditional fixation, CurvaFix notes, is not well suited to every patient or surgical scenario. Plates and straight screws can struggle in thin, curved, or osteoporotic bone - exactly the anatomy where fragility fractures occur. The consequence is longer surgeries, larger incisions, and patients who stay off their feet longer than anyone wants.
The only device capable of following the natural bone shape and filling the space within the pelvis.
The implant is curved to match the natural corridor of the pelvis, so it tracks the bone instead of fighting it.
A threaded, self-tapping distal end and a proximal driving-torque interface let surgeons steer the rodscrew along the bone.
By filling the intramedullary space, the device shares load across the fracture for strong, stable fixation.
The practical pitch to a surgeon is concrete: a single small incision instead of open plating, a shorter procedure, and patients the company believes can bear weight and walk sooner. CurvaFix has cited potential operating-room savings of more than $6,000 per case versus bone-plate procedures - the rare combination of a less invasive approach that may also cost less.
A directional look at what CurvaFix argues its curved intramedullary approach improves, relative to traditional plate-and-screw fixation. Figures are illustrative of the company's positioning, not a clinical benchmark.
The flagship curved, steerable intramedullary implant for pelvic fracture fixation - threaded self-tapping distal end, proximal driving-torque interface - delivering strong internal fixation through a single small incision.
FDA 510(k) clearance for a smaller-diameter version, expanding the range of patients and pelvic anatomy that can be treated.
A next-generation low-profile intramedullary nailing system positioned for less invasive stabilization and early weight-bearing.
CurvaFix sells B2B to orthopedic and trauma surgeons and the hospitals and trauma centers where they operate, supported by a direct sales and commercial team. Its patients span high-energy pelvic trauma and low-energy fragility fractures.
The default alternative is traditional bone plates and straight percutaneous screws. In the broader orthopedic-trauma market, the incumbents are names like DePuy Synthes, Stryker, Zimmer Biomet, and Smith+Nephew - making CurvaFix's curved niche its wedge.
The company is a focused, surgeon-founded medtech operation - 38 employees at last count - built to turn a single clinical insight into a standard of care. That focus is also its strategy: own the curved-bone problem the incumbents' straight hardware handles poorly.
CurvaFix was founded by surgeon Dr. Robert Meek, who remains surgeon founder and strategic medical advisor. Founding CEO Steve Dimmer led the company through its early clinical years. In July 2023 - alongside a $39 million Series C led by MVM Partners with participation from Sectoral Asset Management - Mark Foster became president and CEO, bringing more than two decades of orthopedic and medical-device leadership from Trice Medical, Smith+Nephew, and Boston Scientific.
Dr. Robert Meek founded the company with a vision to develop a better way to repair fractures of the curved bones of the pelvis.
Led by MVM Partners with Sectoral Asset Management; total raised to roughly $60M to fund a nationwide launch.
Joined July 2023 from Trice Medical; 24+ years across orthopedics, sports medicine, and medical devices.
Pelvic and acetabular fracture surgery pioneer; now strategic medical advisor to the company.
Dr. Robert Meek founds the company around curved intramedullary fixation, with Steve Dimmer as founding CEO.
The first surgical procedure using the CurvaFix Rodscrew repairs a pelvic fracture.
A 510(k) clearance for a smaller-diameter IM Implant broadens the treatable patient population.
MVM Partners leads a $39M round; Mark Foster becomes president and CEO.
CurvaFix promotes its next-generation Low Profile intramedullary nailing system.
The CurvaFix IM Implant, a curved, steerable intramedullary rodscrew for repairing pelvic fractures that follows the natural shape of the bone through a single small incision.
Instead of applying straight plates and screws to the bone surface, CurvaFix places a curved implant inside the bone canal, matching pelvic anatomy, filling the intramedullary space, and sharing load for stronger, less invasive fixation.
Yes. CurvaFix received FDA 510(k) clearance for its Rodscrew system and, in November 2022, for a smaller-diameter IM Implant. It is cleared for use in the United States.
It was founded by surgeon Dr. Robert Meek with founding CEO Steve Dimmer. In July 2023, Mark Foster became president and CEO.
CurvaFix closed a $39 million Series C in July 2023 led by MVM Partners, bringing total capital raised to roughly $60 million.
▶ Video: search the CurvaFix YouTube channel (@curvafix5637) for IM Implant product demos, surgical technique animations, and surgeon interviews.